by Combat Cancer | Apr 12, 2025 | News
While lifestyle and environmental factors play a significant role in the development of bowel cancer, there can also be a hereditary component in a small number of cases. Understanding these underlying genetic causes is essential for early diagnosis and intervention,...
by Combat Cancer | Apr 5, 2025 | News
We are proud to announce our upcoming HIVEC®-HEAT Study, which is set to commence enrolment in May 2025. This trial represents a major milestone in the search for effective and less aggressive forms of treatment for non-muscle invasive bladder cancer (NMIBC). The...
by Combat Cancer | Mar 29, 2025 | News
Ovarian cancer is one of the most challenging and elusive cancers affecting women. According to data from Cancer Research UK (CRUK)*, the estimated lifetime risk of being diagnosed with ovarian cancer is estimated to be 1 in 56 – about 2% – for women born...
by Combat Cancer | Mar 22, 2025 | News
New Hope for Patients with BCG-Unresponsive NMIBC Combat Medical is proud to announce the commencement of the HIVEC®-HEAT phase 3 trial – the main aim being to evaluate the effectiveness of our hyperthermic intravesical chemotherapy (HIVEC®) treatment with 80mg...
by Combat Cancer | Mar 14, 2025 | News
Colorectal cancer (CRC) is one of the most common malignancies worldwide, with lifestyle and dietary factors playing huge roles in its development. Recent research at Mass General Brigham has highlighted the potential of probiotics, particularly strains like...
by Combat Cancer | Mar 7, 2025 | News
Ovarian Cancer Awareness Month is observed every March in the UK, with its aim being to educate the public, support those affected, and advocate for better research and early detection. Around 7,400 women are diagnosed with ovarian cancer each year in the UK....
Recent Comments